Literature DB >> 6744273

Identification of a chemoattractant for fibroblasts produced by human breast carcinoma cell lines.

W E Gleiber, E Schiffmann.   

Abstract

Serum-free, conditioned media from the human breast tumor cell line ZR-75-1 and three other breast tumor cell lines were each found to contain a potent chemoattractant for fibroblasts. The chemoattractant activity was characterized and found to reside in a high-molecular-weight (Mr greater than 100,000) protein. This activity was stable to heating to 56 degrees and from pH 3 to 11, but it was sensitive to trypsin and pepsin treatment and to reduction. When crude attractant was placed in vivo in a slowly releasing pump, a fibrous tissue mass that formed at the releasing site within 11 days was 3- to 5-fold larger than was that observed with pumps containing control medium. It is likely that the production of a chemoattractant for fibroblasts by breast tumor cells might contribute to the fibrotic involvement that is common in breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6744273

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Stochastic modelling of biased cell migration and collagen matrix modification.

Authors:  Andreas Groh; Alfred K Louis
Journal:  J Math Biol       Date:  2009-12-10       Impact factor: 2.259

2.  Identification, paracrine generation, and possible function of human breast carcinoma myofibroblasts in culture.

Authors:  L Rønnov-Jessen; B Van Deurs; M Nielsen; O W Petersen
Journal:  In Vitro Cell Dev Biol       Date:  1992-04

3.  Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122.

Authors:  A E Postlethwaite; J M Seyer
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

4.  Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts.

Authors:  A A Colletta; L M Wakefield; F V Howell; K E van Roozendaal; D Danielpour; S R Ebbs; M B Sporn; M Baum
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

5.  17beta-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response.

Authors:  E C Chinje; K J Williams; B A Telfer; P J Wood; A J van der Kogel; I J Stratford
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

6.  Proliferative behaviour of an oestrogen sensitive rat mammary tumour: evidence for a paracrine interaction between tumour and stroma.

Authors:  M G Ormerod; J C Titley; T A Smith; A L Tombs; S Eccles
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

7.  A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.

Authors:  O Skalli; P Ropraz; A Trzeciak; G Benzonana; D Gillessen; G Gabbiani
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

8.  Human breast cancer cells contain a phosphoramidon-sensitive metalloproteinase which can process exogenous big endothelin-1 to endothelin-1: a proposed mitogen for human breast fibroblasts.

Authors:  K V Patel; M P Schrey
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.